Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$2.95 USD
+0.07 (2.43%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $2.99 +0.04 (1.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ADVM 2.95 +0.07(2.43%)
Will ADVM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ADVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADVM
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
Bet on 5 Top-Ranked Stocks With Rising P/E
Other News for ADVM
Is ADVM building bearish momentum? Directional Movement Crossover Bearish shows up after sliding 4.64%
NR7 appears for ADVM after 1.63% move
Is ADVM showing downside potential? 20 Day Moving Average Resistance shows up after advancing 1.66%
Is ADVM building bearish momentum? Fell Below 20 Day Moving Average shows up after slipping 3.82%
Is ADVM likely to continue higher? Non-ADX 1,2,3,4 Bullish shows up after tumbling 5.14%